위치: Australia Pavilion, World Expo 2025, Osaka
날짜:
이벤트: Continuing to shape the future of early-phase research, Novotech will attend the upcoming Australia Early-Phase Clinical Trials Forum, hosted by Austrade during the Health and Well-being Theme Week at World Expo 2025 Osaka. Held at the Australia Pavilion, the forum will spotlight Australia’s global leadership in early-phase clinical research and foster new collaborations between Australian and Japanese biotech and pharma stakeholders. As the leading Australia-based CRO, Novotech is widely recognized for its depth of therapeutic expertise, strong site networks, and proven ability to support biotech sponsors through every phase of development. With a longstanding presence in Australia and deep regional integration across Asia-Pacific, North American and Europe, Novotech combines regulatory and scientific expertise with operational excellence to deliver accelerated, high-quality clinical trial outcomes. The company’s consistent recognition as a top-performing CRO, including multiple Frost & Sullivan Asia-Pacific Biotech CRO of the Year awards, reinforces its leadership in the region. Novotech’s team will include Dr. Yooni Kim, Managing Director, Asia-Pacific, and Calvin Tzeng, Business Development director. Dr. Kim will join a distinguished panel of industry leaders to share insights on the latest trends and practical strategies in supporting international biotech sponsors. The panel discussion, titled "Australia’s Early Phase Clinical Trial Capabilities", will take place from 14:20–15:20 and feature real-world experiences that showcase Australia’s regulatory efficiency, scientific excellence, and sponsor-centric environment. Schedule a meeting with us on this page to learn how Novotech can help you leverage Australia’s clinical trial ecosystem to accelerate your development plans in the Asia-Pacific region.